XML 37 R23.htm IDEA: XBRL DOCUMENT v3.25.0.1
Income Taxes
12 Months Ended
Dec. 31, 2024
Income Tax Disclosure [Abstract]  
Income Taxes

NOTE 15 - INCOME TAXES

The domestic and foreign components of income before provision for income taxes are as follows for the years ended December 31:

 

 

 

2024

 

 

2023

 

 

2022

 

Domestic

 

$

134,068

 

 

$

83,742

 

 

$

80,372

 

Foreign

 

 

3,990

 

 

 

12,805

 

 

 

3,608

 

 Income before income taxes

 

$

138,058

 

 

$

96,547

 

 

$

83,980

 

 

Income tax expense consisted of the following for the years ended December 31:

 

 

 

2024

 

 

2023

 

 

2022

 

Current:

 

 

 

 

 

 

 

 

 

Federal

 

$

41,276

 

 

$

28,108

 

 

$

8,413

 

State

 

 

16,851

 

 

 

10,380

 

 

 

2,686

 

Foreign

 

 

1,647

 

 

 

2,247

 

 

 

1,661

 

Total current

 

 

59,774

 

 

 

40,735

 

 

 

12,760

 

Deferred:

 

 

 

 

 

 

 

 

 

Federal

 

 

(21,055

)

 

 

(20,279

)

 

 

4,264

 

State

 

 

(10,861

)

 

 

(6,915

)

 

 

3,607

 

Foreign

 

 

30

 

 

 

394

 

 

 

(894

)

Total deferred

 

 

(31,886

)

 

 

(26,800

)

 

 

6,977

 

Income tax expense

 

$

27,888

 

 

$

13,935

 

 

$

19,737

 

 

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and income tax purposes.

Deferred tax assets (liabilities) consisted of the following at December 31:

 

 

2024

 

 

2023

 

Deferred Tax Assets

 

 

 

 

 

 

Allowance for expected credit losses

 

$

1,648

 

 

$

1,213

 

Accrued paid time off

 

 

3,525

 

 

 

3,039

 

State net operating loss carryforward

 

 

456

 

 

 

500

 

Stock-based compensation

 

 

6,076

 

 

 

5,523

 

Deferred compensation

 

 

6,568

 

 

 

5,765

 

Foreign tax credits

 

 

8,151

 

 

 

8,035

 

State tax credits

 

 

1,923

 

 

 

686

 

Foreign exchange

 

 

4,345

 

 

 

3,591

 

Foreign deferred

 

 

333

 

 

 

441

 

Accrued bonus

 

 

6,393

 

 

 

5,830

 

Capital loss

 

 

1,020

 

 

 

1,054

 

Facilities impairment

 

 

2,611

 

 

 

3,092

 

Capitalized research expenses

 

 

70,617

 

 

 

47,019

 

Depreciation

 

 

402

 

 

 

 

Accrued liabilities and other

 

 

1,364

 

 

 

2,682

 

Lease liabilities

 

 

54,263

 

 

 

58,538

 

 

 

 

169,695

 

 

 

147,008

 

Less: Valuation Allowance

 

 

(9,627

)

 

 

(9,021

)

Total Deferred Tax Assets

 

 

160,068

 

 

 

137,987

 

 

 

 

 

 

 

 

Deferred Tax Liabilities

 

 

 

 

 

 

Payroll taxes

 

 

(939

)

 

 

(725

)

Unbilled revenue

 

 

(184

)

 

 

(284

)

Depreciation

 

 

 

 

 

(2,128

)

Amortization

 

 

(108,009

)

 

 

(107,201

)

Deferred gain and other

 

 

(2,543

)

 

 

(2,202

)

Lease assets - right-of-use

 

 

(46,790

)

 

 

(51,622

)

Total Deferred Tax Liabilities

 

 

(158,465

)

 

 

(164,162

)

Total Net Deferred Tax Assets (Liabilities)

 

$

1,603

 

 

$

(26,175

)

The Company measures certain deferred tax assets and liabilities based on the rates at which they are expected to reverse in the future, which is 27.0%.

Effective for tax years beginning after January 1, 2022, research and development costs are required to be capitalized and amortized over a period of five years for domestic and fifteen years for foreign research and development for income tax purposes. As a result of the capitalization, the Company recognized increases of $23.6 million and $28.1 million in deferred tax asset for the years ended December 31, 2024 and 2023, respectively.

As of December 31, 2024, the cumulative foreign tax credit carryforward balance increased by approximately $0.1 million and the valuation allowance required increased by approximately $0.1 million. No additional income taxes have been provided for any undistributed foreign earnings not subject to the transition tax. No additional deferred income taxes have been provided for the $5.0 million of additional favorable outside basis differences inherent in these foreign entities as of December 31, 2024 because these amounts continue to be permanently reinvested in foreign operations.

As of December 31, 2024, the Company has net operating loss (“NOL”) carryforwards for state income tax purposes of approximately $5.9 million, which expire between 2029 and 2034. The Company acquired these NOLs as a result of its purchase of a business in November 2014. IRC Section 382 imposes an annual limitation on the use of a corporation’s NOLs, tax credits and other carryovers after an “ownership change” occurs. Section 382 imposes an annual limitation on the amount of post-ownership change taxable income a corporation may offset with pre-ownership change NOLs and credits. In general, the annual limitation is determined by multiplying the value of the corporation’s stock immediately before the ownership change (subject to certain adjustments) by the applicable long-term tax-exempt rate. Any unused portion of the annual limitation is available for use in future years until such NOLs are scheduled to expire (in general, NOLs may be carried forward 15 to 20 years). The Company established a full valuation allowance of approximately $0.5 million against the portion of the deferred tax asset which it is more-likely-than-not that it will not be recoverable (e.g. expiration of the statute of limitations, etc.)

As of December 31, 2024, the Company had gross state income tax credit carryforwards of approximately $2.4 million, which expire between 2025 and 2035. A deferred tax asset of approximately $1.9 million, net of federal benefit, has been established related to these state income tax credit carryforwards as of December 31, 2024.

The need to establish valuation allowances for deferred assets is based on a more-likely-than-not threshold that the benefit of such assets will be realized in future periods. Appropriate consideration has been given to all available evidence, including historical operating results, projections of taxable income, and tax planning alternatives. The Company concluded that a $0.4 million valuation allowance was required for tax attributes related to specified state jurisdictions, a $1.0 million valuation allowance was required for tax attributes related to capital loss carryforwards, and an additional $8.1 million valuation allowance is required against our U.S. foreign tax credit carryforwards.

The total amount of unrecognized tax benefits as of December 31, 2024 and 2023 was $25.8 million and $24.1 million, respectively, which includes $15.0 million and $9.0 million, respectively, of tax positions that, if recognized, would impact the effective rate. The unrecognized tax benefits and the related accrued interest are part of other long-term liabilities on the Company’s consolidated balance sheets.

The components of unrecognized tax benefits, excluding penalty and interest, are as follows at December 31:

 

 

2024

 

 

2023

 

U.S. transfer pricing

 

$

 

 

$

145

 

India transfer pricing

 

 

 

 

 

164

 

Section 41 tax credit

 

 

15,042

 

 

 

8,736

 

Section 174 expense capitalization

 

 

10,798

 

 

 

15,086

 

 Total

 

$

25,840

 

 

$

24,131

 

The unrecognized tax benefit reconciliation, excluding penalty and interest, is as follows:

 

Unrecognized tax benefits at January 1, 2022

 

$

450

 

Decrease attributable to tax positions taken during the current period

 

 

(305

)

Unrecognized tax benefits at December 31, 2022

 

 

145

 

Increase attributable to tax positions taken during a prior period

 

 

19,845

 

Increase attributable to tax positions taken during the current period

 

 

4,141

 

Unrecognized tax benefits at December 31, 2023

 

 

24,131

 

Decrease attributable to tax positions taken during a prior period

 

 

(4,597

)

Increase attributable to tax positions taken during the current period

 

 

6,306

 

Unrecognized tax benefits at December 31, 2024

 

 

25,840

 

 

The Company’s 2021, 2022, and 2023 tax years remain subject to examination by the Internal Revenue Service for federal tax purposes. Certain significant state and foreign tax jurisdictions are also either currently under examination or remain open under the statutes of limitation and subject to examination for the tax years from 2020, 2021, 2022, and 2023.

Although the Company believes it has adequately provided for all uncertain tax positions, amounts asserted by taxing authorities could be greater than the Company’s accrued position. Accordingly, additional provisions on federal, state, and foreign income tax related matters could be recorded in the future as revised estimates are made or the underlying matters are effectively settled or otherwise resolved. Conversely, the Company could settle positions with the tax authorities for amounts lower than have been accrued. The Company believes it is reasonably possible that, during the next 12 months, the Company’s liability for uncertain tax positions may not change.

The Company’s provision for income taxes differs from the federal statutory rate. The differences between the statutory rate and the Company’s provision are as follows for the years ended December 31:

 

 

2024

 

 

2023

 

 

2022

 

Taxes at statutory rate

 

 

21.0

%

 

 

21.0

%

 

 

21.0

%

State taxes, net of federal benefit

 

 

6.0

%

 

 

6.0

%

 

 

5.8

%

Foreign tax rate differential

 

 

(0.1

)%

 

 

(0.2

)%

 

 

0.1

%

Executive compensation

 

 

1.8

%

 

 

1.7

%

 

 

2.2

%

Other permanent differences

 

 

(0.4

)%

 

 

(0.3

)%

 

 

2.0

%

Global intangible low-taxed income (GILTI)

 

 

 

 

 

0.3

%

 

 

 

Prior year tax adjustments

 

 

(2.0

)%

 

 

(6.4

)%

 

 

(1.1

)%

Deferred impact of state rate change

 

 

0.1

%

 

 

0.5

%

 

 

0.6

%

Worthless stock deduction

 

 

 

 

 

(5.1

)%

 

 

(4.6

)%

Unrecognized tax benefits

 

 

4.0

%

 

 

9.0

%

 

 

(0.4

)%

Capital loss

 

 

 

 

 

(3.8

)%

 

 

 

Valuation allowance

 

 

1.3

%

 

 

2.0

%

 

 

0.7

%

Equity-based compensation

 

 

(1.7

)%

 

 

(1.1

)%

 

 

(1.3

)%

Tax credits

 

 

(9.8

)%

 

 

(9.2

)%

 

 

(1.5

)%

Taxes at effective rate

 

 

20.2

%

 

 

14.4

%

 

 

23.5

%

 

During 2023, the Company restructured the ownership of its Canadian entities for tax purposes resulting in a 3.8% decrease in the Company’s effective income tax rate for the year ended December 31, 2023.

During 2023, the Company liquidated one of its U.K. subsidiaries as part of the wind-down of its commercial marketing business resulting in a reduction in the Company’s effective income tax rate of 5.1% for the year ended December 31, 2023.

During 2024 and 2023, the Company completed its annual true-up of the prior year income tax provision in connection with the filing of its U.S. federal & state income tax returns. As a result of that process, the Company recorded changes in the estimate of certain tax credits it is eligible to claim with its income tax return filings that resulted in decreases of 2.0% and 6.4%, respectively, in the Company’s effective income tax rates for the years ended December 31, 2024 and 2023.